Albert A. De Vera

Combining PI3K/Akt/mTOR Inhibition With Chemotherapy

S. Reznik, Albert A. De Vera, A. Vera, 2019, Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy.

Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.

Zhe-Sheng Chen, Pranav Gupta, S. Reznik, 2019, Cancer letters.